{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:14:00Z","timestamp":1764656040333,"version":"3.37.3"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CDC, Ministry of Health and Welfare, Taiwan","award":["MOHW105-CDC-C-315-123104"],"award-info":[{"award-number":["MOHW105-CDC-C-315-123104"]}]},{"name":"CDC, Ministry of Health and Welfare, Taiwan","award":["MOHW106-CDC-C-315-113701"],"award-info":[{"award-number":["MOHW106-CDC-C-315-113701"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0200755","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T17:56:55Z","timestamp":1531763815000},"page":"e0200755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting"],"prefix":"10.1371","volume":"13","author":[{"given":"Ting-Yi","family":"Chiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Yuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-6801","authenticated-orcid":true,"given":"Ruwen","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global tuberculosis report 2017. Geneva 2017. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/<\/ext-link>."},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"e0165222","DOI":"10.1371\/journal.pone.0165222","article-title":"Population-based drug resistance surveillance of multidrug-resistant tuberculosis in Taiwan, 2007\u20132014","volume":"11","author":"PH Chuang","year":"2016","journal-title":"PLoS One"},{"key":"ref3","unstructured":"World Health Organization. Implementing tuberculosis diagnostics: A policy framework. Geneva2015. http:\/\/www.who.int\/tb\/publications\/implementing_TB_diagnostics\/en\/<\/ext-link>."},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/JCM.01332-06","article-title":"Direct detection of Mycobacterium tuberculosis<\/italic> complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay","volume":"44","author":"H Traore","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"9776","key":"ref5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"CC Boehme","year":"2011","journal-title":"Lancet"},{"key":"ref6","unstructured":"World Health Organization. Global tuberculosis report 2015. Geneva2015. http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf<\/ext-link>."},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jinf.2012.02.012","article-title":"Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: a meta-analysis","volume":"64","author":"K Chang","year":"2012","journal-title":"The Journal of infection"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"e0150321","DOI":"10.1371\/journal.pone.0150321","article-title":"GenoType MTBDRplus<\/italic> assay for rapid detection of multidrug resistance in Mycobacterium tuberculosis<\/italic>: a meta-analysis","volume":"11","author":"Y Bai","year":"2016","journal-title":"PLoS One"},{"key":"ref9","unstructured":"World Health Organization. The use of molecular line probe assays for the detection of resistance to second-line antituberculosis drugs. Geneva2016. http:\/\/www.who.int\/tb\/publications\/policy-guidance-molecular-line\/en\/<\/ext-link>."},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic performance of the new version (v2.0) of GenoType MTBDRsl<\/italic> assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study","volume":"53","author":"E Tagliani","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref11","first-page":"343","article-title":"American Thoracic Society. Diagnostic standards and classification of tuberculosis and other mycobacterial diseases (14th edition)","volume":"123","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3343\/alm.2015.35.5.494","article-title":"Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis<\/italic> isolates in Myanmar","volume":"35","author":"WW Aung","year":"2015","journal-title":"Ann Lab Med"},{"key":"ref13","unstructured":"World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organization; 2003. http:\/\/whqlibdoc.who.int\/publications\/2003\/9241546336.pdf<\/ext-link>"},{"key":"ref14","unstructured":"Taiwan CDC. Taiwan Guidelines for TB Diagnosis and Treatment: Taiwan CDC; 2017."},{"key":"ref15","unstructured":"Cepheid. Xpert\u00ae<\/sup> MTB\/RIF assay package insert. Sunnyvale, CA; 2013."},{"key":"ref16","unstructured":"Hain Life Sciences. Genotype MTBDRplus VER 2.0 instruction for use. 2012. Germany. http:\/\/www.ipaqt.org\/wp-content\/uploads\/2013\/02\/MTBDRplusV2_product-insert.pdf<\/ext-link>."},{"key":"ref17","unstructured":"Hain Life Sciences. GenoType MTBDRsl VER 2.0 instructions for use. 2015. Testing instruction. Germany. http:\/\/www.hain-lifescience.de\/en\/instructions-for-use.html<\/ext-link>."},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/JCM.02499-08","article-title":"Performance assessment of the GenoType MTBDRplus<\/italic> test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis<\/italic>","volume":"47","author":"WL Huang","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s10096-017-3082-9","article-title":"Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan","volume":"36","author":"HC Lin","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.meegid.2011.01.021","article-title":"Characteristics of multidrug-resistant Mycobacterium tuberculosis<\/italic> in Taiwan: a population-based study","volume":"11","author":"CW Chang","year":"2011","journal-title":"Infect Genet Evol"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1183\/09031936.00080614","article-title":"An integrated MDR-TB management programme results in favourable outcomes in northern Taiwan","volume":"45","author":"MC Yu","year":"2015","journal-title":"Eur Resp J"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2217\/fmb.11.84","article-title":"Xpert MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance","volume":"6","author":"SD Lawn","year":"2011","journal-title":"Future Microbiol"},{"issue":"Suppl","key":"ref23","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/infdis\/jiu803","article-title":"Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects","volume":"211","author":"M Pai","year":"2015","journal-title":"J Infect Dis"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"e0186139","DOI":"10.1371\/journal.pone.0186139","article-title":"Performance of the Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting","volume":"12","author":"JP Rice","year":"2017","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","article-title":"Diagnostic standards and classification of tuberculosis in adults and children","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"9151","key":"ref26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(98)03406-0","article-title":"Transmission of Mycobacterium tuberculosis<\/italic> from patients smear-negative for acid-fast bacilli","volume":"353","author":"MA Behr","year":"1999","journal-title":"Lancet"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/591974","article-title":"Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands","volume":"47","author":"A Tostmann","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"ref28","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.ijmyco.2016.09.007","article-title":"Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB<\/italic> gene mutations of Mycobacterium tuberculosis<\/italic> detected with XpertMTB\/Rif in Cross River State, Nigeria","volume":"5","author":"EA Ochang","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1471-2334-14-481","article-title":"Rifampicin resistance mutations in the 81 bp RRDR of rpoB<\/italic> gene in Mycobacterium tuberculosis<\/italic> clinical isolates using Xpert MTB\/RIF in Kampala, Uganda: a retrospective study","volume":"14","author":"G Mboowa","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"e0152694","DOI":"10.1371\/journal.pone.0152694","article-title":"Comparison of Xpert MTB\/RIF assay and GenoType MTBDRplus<\/italic> DNA probes for detection of mutations associated with rifampicin resistance in Mycobacterium tuberculosis<\/italic>","volume":"11","author":"A Rahman","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4046\/trd.2017.80.3.270","article-title":"Frequency and type of disputed rpoB<\/italic> mutations in Mycobacterium tuberculosis<\/italic> isolates from South Korea","volume":"80","author":"KW Jo","year":"2017","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: challenging the gold standard","volume":"51","author":"A Van Deun","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/jac\/dkt284","article-title":"Phenotypically occult multidrug-resistant Mycobacterium tuberculosis<\/italic>: dilemmas in diagnosis and treatment","volume":"68","author":"J Ho","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.5588\/ijtld.10.0127","article-title":"Low-level rifampicin-resistant Mycobacterium tuberculosis<\/italic> strains raise a new therapeutic challenge","volume":"15","author":"J Van Ingen","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5588\/ijtld.14.0651","article-title":"Disputed rpoB<\/italic> mutations can frequently cause important rifampicin resistance among new tuberculosis patients","volume":"19","author":"A Van Deun","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","article-title":"Whole-genome sequencing for prediction of Mycobacterium tuberculosis<\/italic> drug susceptibility and resistance: a retrospective cohort study","volume":"15","author":"TM Walker","year":"2015","journal-title":"The Lancet infectious diseases"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis<\/italic>: update 2015","volume":"19","author":"Y Zhang","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","article-title":"Evaluation of genetic mutations associated with Mycobacterium tuberculosis<\/italic> resistance to amikacin, kanamycin and capreomycin: a systematic review","volume":"7","author":"SB Georghiou","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"e01550","DOI":"10.1128\/AAC.01550-17","article-title":"What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi- and extensively drug-resistant tuberculosis","volume":"62","author":"J Heyckendorf","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13059-017-1196-0","article-title":"The within-host population dynamics of Mycobacterium tuberculosis<\/italic> vary with treatment efficacy","volume":"18","author":"A Trauner","year":"2017","journal-title":"Genome Biol"},{"key":"ref41","unstructured":"World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. Geneva: 2016. http:\/\/www.who.int\/tb\/MDRTBguidelines2016.pdf<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0200755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T18:20:15Z","timestamp":1661624415000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0200755"}},"subtitle":[],"editor":[{"given":"Dipankar","family":"Chatterji","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0200755","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,7,16]]}}}